SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Won’t Accept Merck & Co., Inc.'s (JOBS) Application for New Drug

November 3, 2009 | 
1 min read

Bookmark and Share

AP -- U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer’s Lipitor, the world’s top-selling drug.

FDA Approvals Regulatory
Merck & Co. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Facade of AstraZeneca's office in Shanghai, China
FDA
AstraZeneca Gets Full FDA Approval for CMS-Selected Lymphoma Treatment
January 17, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Approvals
Looking Beyond Obesity, Amgen Wins Colorectal Cancer Expansion for Lumakras
January 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Exterior view of the headquarters of the
Complete response letters
Manufacturing Issues Result in FDA Rejection of Atara’s Cell Therapy
January 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
FDA signage at its headquarters in Maryland
Regulatory
After Letter to Commissioner, FDA Finally Gives Vanda Reason for Rejection, Chance for Hearing
January 16, 2025
 · 
2 min read
 · 
Tristan Manalac